NEW YORK (GenomeWeb) – BGI Dx, a subsidiary of BGI, and Italian firm Bioscience Genomics today announced they have signed a five-year framework agreement focused on non-invasive prenatal testing.

The agreement defines terms for the collaboration between the parties, as well as activities and exchanges, and specifically facilitates a technology transfer process for Bioscience Genomics' use of BGI's genetic sequencing technology platforms in the NIPT space.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.